Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment.

Conclusions: Future studies are awaited to define best candidates for novel agents approved in the second line of treatment for HCC. PMID: 32655640 [PubMed]
Source: Journal of Oncology - Category: Cancer & Oncology Tags: J Oncol Source Type: research